Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Dr. Reddy's Laboratories Ltd

NSE: DRREDDY · BSE: 500124 · Pharmaceuticals & Biotechnology · 10 announcements

Share price: ₹1,201.00
Market cap: ₹1,00,245 Cr
Revenue (annual): ₹33,700 Cr
Net profit (annual): ₹4,196 Cr
P/E (TTM): 31.1×Sector 50.4×
Promoter holding: 26.64%+0.01% QoQ
FII holding: 20.67%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 3 Financial Results 2 Price Movement Clarification 1 Partnership 1 Employee Stock Options 1 Business Update 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

22 Jul 2026 16:17 IST BSE

Financial Results

Dr. Reddy's Laboratories Q1 FY27 Results: Net Profit ₹435.6 Cr, Down 69.1% YoY

Dr. Reddy's Laboratories Ltd reported revenue from operations of ₹8,100 Cr (-5.5% YoY) and net profit of ₹435.6 Cr (-69.1% YoY) for Q1 FY27.

Key figure: Net profit ₹435.6 Cr · -69.1% YoY

Open full results → Read the filing ↗

12 May 2026 16:40 IST BSE

Financial Results

Dr. Reddy's Laboratories Q4 FY26 Results: Net Profit ₹221.3 Cr, Down 86.1% YoY

Dr. Reddy's Laboratories Ltd reported revenue from operations of ₹7,546 Cr (-11.5% YoY) and net profit of ₹221.3 Cr (-86.1% YoY) for Q4 FY26.

Key figure: Net profit ₹221.3 Cr · -86.1% YoY

Open full results → Read the filing ↗